Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Bayer
Taproot Health
Quadriga Biosciences, Inc.
Tocagen Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Siemens Molecular Imaging